384 top medical experts on Juvenile Myelomonocytic Leukemia across 37 countries and 26 U.S. states, including 235 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Juvenile Myelomonocytic Leukemia: A leukemia affecting young children characterized by splenomegaly, enlarged lymph nodes, rashes, and hemorrhages. Traditionally classed as a myeloproliferative disease, it is now considered a mixed myeloproliferative-mylelodysplastic disorder.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Myeloid Leukemia (1,836), Myelodysplastic-Myeloproliferative Diseases (814).
  4. Clinical Trials ClinicalTrials.gov : at least 286 including 32 Active, 131 Completed, 74 Recruiting
  5. Synonyms: Juvenile Chronic Myelogenous Leukemia


  

        

                    


    Computing Expert Listing ...

);